Behavior of delay times in thrombolytic treatment of patients with acute myocardial infarction

被引:0
作者
Diaz, Juan A. Rodriguez [1 ]
Portuondo, Raciel Mariol [2 ]
机构
[1] Hosp Gen Docente Martin Chang Puga Nuevitas Camag, Serv Cardiol, Camaguey, Cuba
[2] Hosp Gen Docente Martin Chang Puga Nuevitas Camag, Serv Terapia Intensiva, Camaguey, Cuba
来源
CORSALUD | 2022年 / 14卷 / 03期
关键词
Myocardial infarction; Treatment; Thrombolytic therapy; Delayed treatment; RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Occlusion of a coronary artery leads to cell death in a period of time ranging from 4-12 hours, this is a dynamic process that can be modified with the restoration of blood flow in the infarct-related vessel; hence the importance of the 'time' factor. Objective: To determine the delay times in the application of the thrombolytic therapy in patients with acute myocardial infarction. Method: A prospective longitudinal descriptive study was carried out, including 579 patients diagnosed with ST-segment elevation myocardial infarction who received thrombolytic therapy at the Hospital General Docente Martin Chang Puga in Nuevitas, Camaguey, Cuba; from January 2000 to December 2019. Demographic variables (age and gender) as well as delay times in the application of thrombolysis were assessed. Results: The predominant age group was 56 to 65 years old (35.2%) as well as males (60.3). Predominant delay times were: patient-time more than two hours, door-to-needle time between 6-12 hours (30.7%), pre-hospital care between 61-180 minutes (56.8%), pain-to-needle time more than 12 hours (34.9%) and overall time to thrombolysis between 6 -12 hours (43.2%). Conclusions: Delay times in the application of the thrombolytic treatment were, in general, abnormally high. Only in a small percentage of patients it was performed within the first two hours after symptoms onset.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 29 条
[1]   The Risk of Cardiovascular Events After an Acute Coronary Event Remains High, Especially During the First Year, Despite Revascularization [J].
Abu-Assi, Emad ;
Lopez-Lopez, Andrea ;
Gonzalez-Salvado, Violeta ;
Redondo-Dieguez, Alfredo ;
Pena-Gil, Carlos ;
Bouzas-Cruz, Noelia ;
Raposeiras-Roubin, Sergio ;
Riziq-Yousef Abumuaileq, Rami ;
Garcia-Acuna, Jose M. ;
Gonzalez-Juanatey, Jose R. .
REVISTA ESPANOLA DE CARDIOLOGIA, 2016, 69 (01) :11-18
[2]  
Allen DR, 2010, MEDISAN, V14
[3]  
[Anonymous], 1995, Arch Intern Med, V155, P1481
[4]  
[Anonymous], 1986, LANCET, V1, P397
[5]   Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury [J].
Chapman, Andrew R. ;
Shah, Anoop S. V. ;
Lee, Kuan Ken ;
Anand, Atul ;
Francis, Oliver ;
Adamson, Philip ;
McAllister, David A. ;
Strachan, Fiona E. ;
Newby, David E. ;
Mills, Nicholas L. .
CIRCULATION, 2018, 137 (12) :1236-1245
[6]  
de la Noval Garcia R, 2011, REV CUBAN CARDIOL, V17, P4
[7]   Fibrinolytic treatment for elderly patients with acute myocardial infarction [J].
Estess, JM ;
Topol, EJ .
HEART, 2002, 87 (04) :308-311
[8]   Cardiac Imaging to Evaluate Left Ventricular Diastolic Function [J].
Flachskampf, Frank A. ;
Biering-Sorensen, Tor ;
Solomon, Scott D. ;
Duvemoy, Olov ;
Bjemer, Tomas ;
Smiseth, Otto A. .
JACC-CARDIOVASCULAR IMAGING, 2015, 8 (09) :1071-1071
[9]   Standardized End Point Definitions for Coronary Intervention Trials The Academic Research Consortium-2 Consensus Document [J].
Garcia-Garcia, Hector M. ;
McFadden, Eugene P. ;
Farb, Andrew ;
Mehran, Roxana ;
Stone, Gregg W. ;
Spertus, John ;
Onuma, Yoshinobu ;
Morel, Marie-angele ;
van Es, Gerrit-Anne ;
Zuckerman, Bram ;
Fearon, William F. ;
Taggart, David ;
Kappetein, Arie-Pieter ;
Krucoff, Mitchell W. ;
Vranckx, Pascal ;
Windecker, Stephan ;
Cutlip, Donald ;
Serruys, Patrick W. .
CIRCULATION, 2018, 137 (24) :2635-2650
[10]  
Greig D, 2008, REV MED CHILE, V136, P1098, DOI /S0034-98872008000900002